PositiveID Corp. has received 510(k) clearance from the Food and Drug Administration to market its "iglucose" technology for diabetes management.

The iglucose product enables the transmission of readings from a data-capable glucometer to a diabetes management Web portal where diabetics can gather and track their glucose levels and permit access to family members, caregivers and clinicians. The product eliminates the keeping of paper-based logbooks and helps increase self-management, according to the Delray Beach, Fla.-based vendor.

Data is transmitted via cellular networks; a wireless data plan is not required. The company has wireless infrastructure agreements with AT&T in the United States and Rogers Communications in Canada, and continues to solicit other companies.

Glucose meters supporting the system include Johnson & Johnson's LifeScan OneTouch and Nipro Diagnostic's True products, with PositiveID seeking additional partners. The company is targeting iglucose to health insurers and home health providers. More information is available at iglucose.com.

 

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access